Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?
India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…
India’s Pharma Industry Raises Concerns Of Shortage & Costlier Medicine For Americans Over Proposed US Tariffs
The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential…








